07-06-12 BioGaia signs agreement with a company in the Otsuka group for dog product


Press Release                                                                   
12 june 2007                                                                    




   BioGaia signs agreement with a company in the Otsuka group for dog product   


BioGaia has signed an agreement with Earth Biochemical Co. Ltd, a company in the
Otsuka group, which gives Earth Biochemical the right to sell in Japan oil drops
for dogs, containing a Reuteri bacteria, specifically developed for dogs.       

The product will be sold through veterinary clinics and will be part of a larger
portfolio of products for dogs and cats. In Japan there are 13 million dogs and 
around 8000 veterinary clinics.                                                 

Earth Biochemical have been specialists in animal health products since 1973 and
have sales today to both veterinary surgeons and pet shops.                     

”This is an interesting agreement in several ways. Firstly, it is our first     
agreement concerning household pets and secondly, it is a unique product which  
we can sell in many other markets.” says Peter Rothschild, President of BioGaia.











Latest press releases from BioGaia:                                             
2007-04-25	Annual General Meeting of BioGaia                                    
2007-04-24	BioGaia AB Interim Report 1 January - 31 March 2007                  
2007-04-17	BioGaia signs agreement with Sunstar                                 



For additional information contact:                                             
Peter Rothschild, Managing Director, telephone: +46 8 - 555 293 00,             
Jan                                                                             
Annwall, Deputy Managing Director telephone: +46 8 - 555 293 00                 
--------------------------------------------------------------------------------
---------------------------------------------------------------                 
 BioGaia is a biotechnology company that develops, markets and sells probiotic  
 products with documented health benefits. The products are primarily based on  
the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, 
health-enhancing effects. The class B share of the Parent Company BioGaia AB is 
    quoted on the Small Cap list of the Nordic Stock Exchange in Stockholm.     

                                www.biogaia.com